Doctor profile · Federal record

Dr. Misagh Karimi, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Newport Beach, CA

  • NPI 1770583197
  • Accepts Medicare
  • MIPS 91.9 / 100 · 2023
  • 30 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1601 Avocado Ave
Newport Beach, CA 926607798
(949) 763-2204
fax (949) 536-8036
Mailing address
Po Box 512185
Los Angeles, CA 900510185

Credentials & registration

NPPES · NUCC
NPI registered
July 2005 — 21 yrs on file
Profile last updated
November 6, 2020
Year of graduation
1996 — 30 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
California #A63851
Medicaid
OR #278092

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1770583197. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
63,459
Distinct HCPCS
10
Medicare allowed
$1,196,384
HCPCS Description Services Patients Avg allowed
J0185 Injection, aprepitant, 1 mg 15,470 31 $2
J1439 Injection, ferric carboxymaltose, 1 mg 15,000 12 $1
J9271 Injection, pembrolizumab, 1 mg 12,600 20 $48
J3111 Injection, romosozumab-aqqg, 1 mg 4,410 13 $10
J2405 Injection, ondansetron hydrochloride, per 1 mg 2,720 52 $0
J0897 Injection, denosumab, 1 mg 2,700 19 $23
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg 2,280 20 $45
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,762 40 $0
J0640 Injection, leucovorin calcium, per 50 mg 1,459 13 $4
J9190 Injection, fluorouracil, 500 mg 859 13 $2

In context: peer comparison

Among 9 peers in this city , average services per provider: 1,060. This provider delivers 60× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$144,126
Transactions
134
Manufacturers
11
Payer (manufacturer) Industry Txns Amount
E.R. Squibb & Sons, L.L.C. 18 $33,816.80
EMD Serono, Inc. 12 $32,963.11
Merck Sharp & Dohme LLC 28 $22,184.34
Takeda Pharmaceuticals U.S.A., Inc. 17 $17,776.65
PFIZER INC. 22 $15,378.52
AstraZeneca Pharmaceuticals LP 11 $11,176.82
Eisai Inc. 7 $6,537.59
Exelixis Inc. 1 $1,620.00
TAIHO ONCOLOGY, INC. 1 $1,400.00
ARRAY BIOPHARMA INC 1 $720.00
Celgene Corporation 16 $551.73

By nature of payment

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
$66,226
Consulting Fee
$47,480
Travel and Lodging
$19,941
Compensation for serving as faculty or as a speaker for a medical education program
$6,365
Food and Beverage
$2,144
Honoraria
$1,620
Grant
$350

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
398
Patients
124
Total drug cost
$43,082
Drug Type Claims Patients Total cost
Dexamethasone Generic 67 31 $1,078
Ondansetron Hcl Generic 55 33 $937
Prochlorperazine Maleate Generic 39 27 $686
Gabapentin Generic 38 15 $948
Lidocaine-Prilocaine (Lidocaine/Prilocaine) Brand 25 18 $423
Doxycycline Hyclate Generic 22 0 $596
Pantoprazole Sodium Generic 22 0 $322
Creon (Lipase/Protease/Amylase) Brand 21 0 $24,084
Eliquis (Apixaban) Brand 20 0 $12,249
Duloxetine Hcl Generic 19 0 $371

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Misagh Karimi's medical specialty?
Dr. Misagh Karimi practices Hematology & Oncology Physician in Newport Beach, CA.
Where does Dr. Misagh Karimi practice?
Dr. Misagh Karimi practices at 1601 Avocado Ave, Newport Beach, CA 926607798. Office phone: 9497632204.
What is Dr. Misagh Karimi's NPI?
Dr. Misagh Karimi's National Provider Identifier (NPI) is 1770583197, issued by NPPES.
Does Dr. Misagh Karimi accept Medicare assignment?
Yes. Dr. Misagh Karimi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Misagh Karimi commonly perform?
Top Medicare-reported procedures in 2023: Injection, aprepitant, 1 mg (HCPCS J0185); Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.